Cross-resistance to cisplatin in cells with acquired resistance to copper

被引：0
作者：
Roohangiz Safaei
Kuniyuki Katano
Goli Samimi
Wiltrud Naerdemann
Jennifer L. Stevenson
Myriam Rochdi
Stephen B. Howell
机构：
[1] University of California San Diego,Department of Medicine 0058
[2] GloboMax Service Group,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2004年 / 53卷
关键词：
Copper; Cisplatin; Resistance; Transport;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：239 / 246
页数：7
相关论文
共 50 条
  • [1] Cross-resistance to cisplatin in cells with acquired resistance to copper
    Safaei, R
    Katano, K
    Samimi, G
    Naerdemann, W
    Stevenson, JL
    Rochdi, M
    Howell, SB
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 53 (03) : 239 - 246
  • [2] Organic cation transporter 3 mediates cisplatin and copper cross-resistance in hepatoma cells
    Guttmann, Sarah
    Chandhok, Gursimran
    Groba, Sara Reinartz
    Niemietz, Christoph
    Sauer, Vanessa
    Gomes, Amanda
    Ciarimboli, Giuliano
    Karst, Uwe
    Zibert, Andree
    Schmidt, Hartmut H.
    ONCOTARGET, 2018, 9 (01) : 743 - 754
  • [3] Acquired resistance to irradiation or docetaxel is not associated with cross-resistance to cisplatin in prostate cancer cell lines
    Donix, Lukas
    Erb, Holger H. H.
    Peitzsch, Claudia
    Dubrovska, Anna
    Pfeifer, Manuel
    Thomas, Christian
    Fuessel, Susanne
    Erdmann, Kati
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (06) : 1313 - 1324
  • [4] Acquired resistance to irradiation or docetaxel is not associated with cross-resistance to cisplatin in prostate cancer cell lines
    Lukas Donix
    Holger H. H. Erb
    Claudia Peitzsch
    Anna Dubrovska
    Manuel Pfeifer
    Christian Thomas
    Susanne Fuessel
    Kati Erdmann
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 1313 - 1324
  • [5] CROSS-RESISTANCE BETWEEN CISPLATIN, ANTIMONY POTASSIUM TARTRATE, AND ARSENITE IN HUMAN TUMOR-CELLS
    NAREDI, P
    HEATH, DD
    ENNS, RE
    HOWELL, SB
    JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (03) : 1193 - 1198
  • [6] Development of cross-resistance between heat and cisplatin or hydroxyurea treatments in FaDu squamous carcinoma cells
    Yang, WL
    Yang-Biggs, G
    Wu, Y
    Ye, XM
    Gallos, G
    Owen, RP
    Ravikumar, TS
    JOURNAL OF SURGICAL RESEARCH, 2003, 111 (01) : 143 - 151
  • [7] Cross-resistance and combined cytotoxic effects of paclitaxel and cisplatin in bladder cancer cells
    Pu, YS
    Chen, J
    Huang, CY
    Guan, JY
    Lu, SH
    Hour, TC
    JOURNAL OF UROLOGY, 2001, 165 (06) : 2082 - 2085
  • [8] Cross-resistance of cisplatin selected cells to anti-microtubule agents: Role of general survival mechanisms
    Patel, Ruchi P.
    Kuhn, Skyler
    Yin, Da
    Hotz, Jordan M.
    Maher, Frances A.
    Robey, Robert W.
    Gottesman, Michael M.
    Horibata, Sachi
    TRANSLATIONAL ONCOLOGY, 2021, 14 (01):
  • [9] Disinfectant resistance mechanisms, cross-resistance, and co-resistance
    Chapman, JS
    INTERNATIONAL BIODETERIORATION & BIODEGRADATION, 2003, 51 (04) : 271 - 276
  • [10] Interaction and cross-resistance of cisplatin and pemetrexed in malignant pleural mesothelioma cell lines
    Kitazono-Saitoh, Miyako
    Takiguchi, Yuichi
    Kitazono, Satoru
    Ashinuma, Hironori
    Kitamura, Atsushi
    Tada, Yuji
    Kurosu, Katsushi
    Sakaida, Emiko
    Sekine, Ikuo
    Tanabe, Nobuhiro
    Tagawa, Masatoshi
    Tatsumii, Koichiro
    ONCOLOGY REPORTS, 2012, 28 (01) : 33 - 40
12345